Stephen M. D. Webster
Thanks, Andy, and good morning, everyone. Let's turn to Slide 4 for a review of our consolidated financial results. In the second quarter, sales were $97.1 million, up 5.8% year-over-year reflecting continued strength across our core defense and aerospace markets. Adjusted EBITDA increased 14.8% to $14 million, delivering a 14.4% margin up from 12.5% in quarter 1, resulting in nearly 200 basis points of sequential margin improvement. Adjusted EPS rose to $0.30, up 25% year-over-year. We generated $1.2 million in cash from operations and net debt ended at $48.2 million with leverage at 0.9x. On the right, the sales bridge highlights a $2.2 million contribution from pricing, including targeted price actions in aerospace. Foreign exchange was a $2 million tailwind and volume and mix added $1.1 million driven by strong MRE and flare demand and continued elevated aerospace shipments. For our adjusted EBITDA walk, the higher pricing was complemented by incremental volume and the higher value mix contribution of $2 million. These gains were partially offset by $2.4 million in headwinds primarily FX from the continued strengthening of sterling, residual inflation and elevated operating expenses. The majority of the higher OpEx reflects increased maintenance, utilities and overhead costs within Elektron, driven by improved throughput to support defense programs. For a full breakdown, please see the detailed waterfall in the appendix on Slide 12. With that, let's move to Slide 5 for a closer look at Elektron's Q2 performance. Elektron delivered another strong quarter with sales increasing 19% year-over-year to $50.1 million adjusted EBITDA rose to $9.1 million, with margins expanding to 18.2%, reflecting favorable mix and disciplined execution, although partially tempered by the higher operating costs. Defense, first response and healthcare was a standout performer, up 43% from the prior year, and demand remains well above historical levels. In transportation, trends were mixed. We saw continued recovery in aerospace alloy volumes, auto catalysis improved sequentially but remains below pre 2023 levels and overall auto activity slowed. Specialty Industrial was also up modestly supported by increased demand for magnesium specialty powders. Overall, Q2 performance in Elektron reflected strong demand in our core end markets, ongoing operational execution and a healthy mix shift supporting top line growth and margin expansion. With that, let's turn to Slide 6 for our Gas Cylinders results. In quarter 2, gas cylinders delivered a solid sequential rebound with sales of $47 million, up 14% from the first quarter. While sales declined 6% year-over-year, we're encouraged by improving momentum in key higher-margin segments. Adjusted EBITDA was $4.9 million, up 23.9% from the first quarter with margins improving to 10.4%, supported by further pricing execution of $2.5 million and disciplined cost control. Specialty Industrial improved 4%, driven by strength in calibration and electronics-related gas cylinders. Transportation also increased 4% led by solid demand in aerospace and especially space exploration, outpacing the ongoing pressures in the alternative fuel market. Defense, first response and healthcare sales declined 15% year-over-year primarily due to the conclusion of the prior year U.S. Air Force SCBA program and short-term softness in medical cylinder contracts. That said, baseline demand in both areas remains steady. Overall, we view Q2 as a solid transition quarter for the segment. Improved mix and stronger contributions from aerospace, space exploration and electronics-related applications, supported sequential gains and margin expansion. This performance reflects a deliberate shift towards higher quality, higher-margin end markets. While clean energy volumes will remains soft, the flexibility of the portfolio has allowed us to adapt and focus on more profitable growth areas. Importantly, the recently announced relocation of composite cylinder production to our Riverside facility is expected to drive meaningful long-term benefits, streamlining our cost structure, enhancing operational efficiency and improving overall alignment across the business. Let's now move to Slide 7 for a review of our updated 2025 guidance. We've improved our full year guidance based on solid performance in the first half and continued strength in our order book. We have narrowed upwards the adjusted EPS range to $0.97 to $1.05 with adjusted EBITDA now between $49 million and $52 million. Projected free cash flow of $20 million to $25 million remains unchanged, but now incorporates the proceeds of the Graphic Arts sale which in turn helps fund the recently announced relocation project in our Gas Cylinders segment. We do now forecast low single-digit year-over-year sales growth versus 2024. Our confidence is supported by good momentum in defense and aerospace, including demand for MREs, UGR-Es and flares as well as a strong backlog. We are maintaining tight control over costs and driving efficiency through site optimization initiatives. The impact of tariffs on our business has been modest to date, we are, though, seeing early signs of pressure in automotive affecting our Elektron business. This factor, when modeled with normal seasonality, is reflected in our latest guidance. We are pleased with our progress at the half year mark and cautiously optimistic about the full year outlook. Now I'd like to pass the call back to Andy.